Toward precision medicine and health: Opportunities and challenges in allergic diseases.
暂无分享,去创建一个
[1] S. Willsie. Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia , 2010 .
[2] Stephen J Galli,et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). , 2014, The Journal of allergy and clinical immunology.
[3] Steve L. Taylor,et al. How much food is too much? threshold doses for allergenic foods , 2002, Current allergy and asthma reports.
[4] Ali A. Faruqi,et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection , 2013, Proceedings of the National Academy of Sciences.
[5] S. Spitzauer,et al. Allergy testing: the role of recombinant allergens , 2006, Clinical chemistry and laboratory medicine.
[6] J. Simon,et al. Overview of Component Resolved Diagnostics , 2013, Current Allergy and Asthma Reports.
[7] Aly A. Khan,et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants , 2015, The ISME Journal.
[8] Stacie M Jones,et al. Sustained Unresponsiveness to Peanut in Subjects Who Have Completed Peanut Oral Immunotherapy , 2014, Pediatrics.
[9] A. Lowe,et al. Perinatal Cat and Dog Exposure and the Risk of Asthma and Allergy in the Urban Environment: A Systematic Review of Longitudinal Studies , 2011, Clinical & developmental immunology.
[10] W. Busse,et al. Biomarkers in asthmatic patients: Has their time come to direct treatment? , 2016, The Journal of allergy and clinical immunology.
[11] S. Durham,et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. , 2009, The Journal of allergy and clinical immunology.
[12] William W Busse,et al. Role of viral respiratory infections in asthma and asthma exacerbations , 2010, The Lancet.
[13] P. Nair. What is an "eosinophilic phenotype" of asthma? , 2013, The Journal of allergy and clinical immunology.
[14] Cezmi A Akdis,et al. Categorization of allergic disorders in the new World Health Organization International Classification of Diseases , 2014, Clinical and Translational Allergy.
[15] S. Wenzel,et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.
[16] L. Noon. Prophylactic inoculation against hay fever. , 1911, International archives of allergy and applied immunology.
[17] R. Bush,et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. , 1988, The Journal of allergy and clinical immunology.
[18] J. Freeman. VACCINATION AGAINST HAY FEVER: REPORT OF RESULTS DURING THE LAST THREE YEARS. , 1914 .
[19] L. Noon,et al. Further observation on the treatment of hay fever by hypodermic inoculation of pollen vaccine , 2017 .
[20] M. Blaser,et al. The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.
[21] G. O'Connor,et al. Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The VDAART Randomized Clinical Trial. , 2016, JAMA.
[22] Scott H Sicherer,et al. Clinical reviews in allergy and immunology , 2022 .
[23] C. Akdis,et al. Advances in allergen immunotherapy: Aiming for complete tolerance to allergens , 2015, Science Translational Medicine.
[24] S. Wenzel,et al. Dupilumab in persistent asthma with elevated eosinophil levels. , 2013, The New England journal of medicine.
[25] Muin J Khoury,et al. Genetics and genomics in practice: The continuum from genetic disease to genetic information in health and disease , 2003, Genetics in Medicine.
[26] Thomas Ferkol,et al. Precision Medicine: At What Price? , 2015, American journal of respiratory and critical care medicine.
[27] C. Akdis,et al. Immunological mechanisms of allergen‐specific immunotherapy , 2011, Allergy.
[28] Lee, Jk,et al. Lebrikizumab treatment in adults with asthma. , 2011 .
[29] S. Wenzel,et al. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies , 2007, The Lancet.
[30] R. Van Ree,et al. How much is too much? Threshold dose distributions for 5 food allergens. , 2015, Journal of Allergy and Clinical Immunology.
[31] C. Davis,et al. Utility of Component-Resolved Diagnostics in Food Allergy , 2015, Current Allergy and Asthma Reports.
[32] Richard M Weinshilboum,et al. Genomics and drug response. , 2011, The New England journal of medicine.
[33] Stephen J. Galli,et al. Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets , 2016, Proceedings of the National Academy of Sciences.
[34] P. Korenblat,et al. Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes , 2014, Current opinion in allergy and clinical immunology.
[35] I. Agache,et al. The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside , 2015, Current Allergy and Asthma Reports.
[36] D. Antonopoulos,et al. Commensal bacteria protect against food allergen sensitization , 2014, Proceedings of the National Academy of Sciences.
[37] H. Williams,et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention , 2014, The Journal of allergy and clinical immunology.
[38] I Sayers,et al. Genetic risk factors for the development of allergic disease identified by genome-wide association , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[39] S. Phipps,et al. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma , 2013, European Respiratory Journal.
[40] S. Dahlén,et al. Predicting asthma morbidity in children using proposed markers of Th2‐type inflammation , 2015, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[41] A. Ponsonby,et al. Cord blood monocyte–derived inflammatory cytokines suppress IL-2 and induce nonclassic “TH2-type” immunity associated with development of food allergy , 2016, Science Translational Medicine.
[42] W. Morgan,et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.
[43] IL-4 receptor α polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist. , 2010, The Journal of allergy and clinical immunology.
[44] K. S. Kim,et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine , 2016, Science.
[45] B. Chipps. Oral Immunotherapy for Treatment of Egg Allergy in Children , 2013, Pediatrics.
[46] K. Bønnelykke,et al. Effect of Vitamin D3 Supplementation During Pregnancy on Risk of Persistent Wheeze in the Offspring: A Randomized Clinical Trial. , 2016, JAMA.
[47] P. Lieberman,et al. Risk multipliers for severe food anaphylaxis , 2015, The World Allergy Organization journal.
[48] N. Khardori. Exposure to Environmental Microorganisms and Childhood Asthma , 2011 .
[49] M. Sears. Predicting asthma outcomes. , 2015, The Journal of allergy and clinical immunology.
[50] R. Hopp. EXPOSURE TO DOGS AND CATS IN THE FIRST YEAR OF LIFE AND RISK OF ALLERGIC SENSITIZATION AT 6 TO 7 YEARS OF AGE , 2003, Pediatrics.
[51] Barmak Modrek,et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.
[52] Shih-Ying Wu,et al. Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children , 2013, The Journal of allergy and clinical immunology.
[53] Charles Auffray,et al. Participatory medicine: a driving force for revolutionizing healthcare , 2013, Genome Medicine.
[54] Adnan Custovic,et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. , 2011, The Journal of allergy and clinical immunology.
[55] G. Roberts,et al. Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy , 2015, Pediatrics.
[56] K. Izuhara,et al. No increase in the serum periostin level is detected in elementary school-age children with allergic diseases. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[57] Ayne,et al. ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE , 1995 .
[58] K. Nadeau,et al. Molecular and cellular mechanisms of food allergy and food tolerance. , 2016, The Journal of allergy and clinical immunology.
[59] E. Bleecker,et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.
[60] A. Litonjua,et al. Vitamin D, the gut microbiome, and the hygiene hypothesis. How does asthma begin? , 2015, American Journal of Respiratory and Critical Care Medicine.
[61] B. Chipps,et al. Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy , 2015, Pediatrics.
[62] T. Betsuyaku,et al. Phenotype of asthma related with high serum periostin levels. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[63] D. Vercelli,et al. Discovering susceptibility genes for asthma and allergy , 2008, Nature Reviews Immunology.
[64] E. Valovirta,et al. Allergy and asthma prevention 2014 , 2014, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[65] K. Izuhara,et al. Recent developments regarding periostin in bronchial asthma. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[66] D. Vercelli,et al. Farm living: effects on childhood asthma and allergy , 2010, Nature Reviews Immunology.
[67] J. Gilbert,et al. The role of the commensal microbiota in the regulation of tolerance to dietary allergens , 2015, Current opinion in allergy and clinical immunology.
[68] E. Israel,et al. Update on reslizumab for eosinophilic asthma , 2015, Expert opinion on biological therapy.
[69] F. Martinez. Gene-environment interactions in asthma: with apologies to William of Ockham. , 2007, Proceedings of the American Thoracic Society.
[70] S. Mosesova,et al. Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids. , 2013, The Journal of allergy and clinical immunology.
[71] C. Mills,et al. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. , 2015, The Journal of allergy and clinical immunology.
[72] Francis S. Collins,et al. Bringing the Common Rule into the 21st Century. , 2015, The New England journal of medicine.
[73] A. Litonjua,et al. Is vitamin D deficiency to blame for the asthma epidemic? , 2007, The Journal of allergy and clinical immunology.
[74] D. Vercelli,et al. Environmental protection from allergic diseases: From humans to mice and back. , 2015, Current opinion in immunology.
[75] Choon-Sik Park,et al. Identification of asthma clusters in two independent Korean adult asthma cohorts , 2012, European Respiratory Journal.
[76] Leroy Hood,et al. Systems Biology and P4 Medicine: Past, Present, and Future , 2013, Rambam Maimonides medical journal.
[77] J. Bousquet,et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. , 2014, Methods.
[78] S. Willsie. Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-Controlled Study , 2012 .
[79] H. Renz,et al. Antisense molecules: A new class of drugs. , 2016, The Journal of allergy and clinical immunology.
[80] N. Paneth,et al. Seven Questions for Personalized Medicine. , 2015, JAMA.
[81] E. Bleecker,et al. Asthma genetics and personalised medicine. , 2014, The Lancet. Respiratory medicine.
[82] Carole Ober,et al. The genetics of asthma and allergic disease: a 21st century perspective , 2011, Immunological reviews.
[83] W. Busse,et al. Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study. , 2014, The Lancet. Respiratory medicine.
[84] R. Hamilton. Allergic sensitization is a key risk factor for but not synonymous with allergic disease. , 2014, The Journal of allergy and clinical immunology.
[85] C. Akdis,et al. Novel immunotherapy vaccine development , 2014, Current opinion in allergy and clinical immunology.
[86] B. Marsland,et al. Microbiome influences on allergy in mice and humans. , 2015, Current opinion in immunology.
[87] The allergy epidemics: 1870-2010. , 2015, The Journal of allergy and clinical immunology.
[88] Ana Sousa,et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.